Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Illumina (ILMN) Stock Forecast & Price Target

Illumina logo
$99.94 +0.77 (+0.77%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Illumina - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold
Based on 19 Analyst Ratings
Sell
2
Hold
11
Buy
6

Based on 19 Wall Street analysts who have issued ratings for Illumina in the last 12 months, the stock has a consensus rating of "Hold." Out of the 19 analysts, 2 have given a sell rating, 11 have given a hold rating, and 6 have given a buy rating for ILMN.

Consensus Price Target

$123.17
23.25% Upside
According to the 19 analysts' twelve-month price targets for Illumina, the average price target is $123.17. The highest price target for ILMN is $200.00, while the lowest price target for ILMN is $80.00. The average price target represents a forecasted upside of 23.25% from the current price of $99.94.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ILMN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Illumina and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ILMN Analyst Ratings Over Time

TypeCurrent Forecast
8/29/24 to 8/29/25		1 Month Ago
7/30/24 to 7/30/25		3 Months Ago
5/31/24 to 5/31/25		1 Year Ago
8/30/23 to 8/29/24
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
8 Buy rating(s)
9 Buy rating(s)
12 Buy rating(s)
Hold
11 Hold rating(s)
9 Hold rating(s)
10 Hold rating(s)
9 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$123.17$125.89$128.15$151.05
Forecasted Upside23.25% Upside18.03% Upside57.49% Upside12.91% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

ILMN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ILMN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Illumina Stock vs. The Competition

TypeIlluminaMedical CompaniesS&P 500
Consensus Rating Score
2.21
2.78
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside24.20% Upside15,720.85% Upside10.25% Upside
News Sentiment Rating
Very Positive News

See Recent ILMN News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/12/2025Daiwa America
5 of 5 stars		 DowngradeStrong-Buy ➝ Hold
8/12/2025Daiwa Capital Markets
2 of 5 stars		 DowngradeOutperform ➝ Neutral$94.00-0.82%
8/4/2025Stephens
4 of 5 stars		 Set TargetOverweight ➝ Overweight$110.00+12.52%
8/4/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Tejas Savant
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetEqual Weight ➝ Equal Weight$100.00 ➝ $105.00+8.45%
8/1/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Conor McNamara
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOutperform ➝ Outperform$118.00 ➝ $126.00+30.04%
8/1/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Kyle Mikson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetHold ➝ Hold$99.00 ➝ $105.00+9.19%
8/1/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Luke Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetUnderweight ➝ Underweight$85.00 ➝ $90.00-7.83%
7/28/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Catherine Ramsey
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetNeutral ➝ Neutral$84.00 ➝ $105.00-3.93%
7/11/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Sung Ji Nam
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeSector Outperform ➝ Sector Perform$125.00+24.94%
7/9/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Patrick Donnelly
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeHold ➝ Strong Sell$85.00 ➝ $80.00-19.41%
7/8/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Vijay Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOutperform ➝ Outperform$116.00 ➝ $128.00+31.76%
5/15/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Westenberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOverweight ➝ Overweight$190.00 ➝ $185.00+129.39%
5/9/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Julia Qin
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetNeutral ➝ Neutral$120.00 ➝ $85.00+12.20%
5/9/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Subbu Nambi
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$122.00 ➝ $114.00+48.17%
2/28/2025Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating		S. Gupta
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeStrong-Buy ➝ Hold
2/28/2025HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold$100.00+12.40%
2/7/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Brennan
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeBuy ➝ Hold$177.00 ➝ $140.00+14.01%
11/5/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$133.00 ➝ $145.00-4.89%
10/17/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$160.00 ➝ $200.00+38.91%
8/28/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Hellweg
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeHold ➝ Buy$150.00+14.59%
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageHold$115.00+10.28%
3/20/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingPositive ➝ Mixed
12/15/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Market Perform
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$175.00+48.76%
12/12/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeNeutral ➝ Underperform$140.00 ➝ $100.00-14.99%
10/12/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$200.00+49.91%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:56 PM ET.


Should I Buy Illumina Stock? ILMN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, August 28, 2025. Please send any questions or comments about these Illumina pros and cons to contact@marketbeat.com.

Illumina
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Illumina, Inc.:

  • The current stock price is around $99, which is significantly lower than its 1-year high of $156.66, indicating potential for recovery and growth.
  • Illumina, Inc. reported earnings per share (EPS) of $1.19 for the latest quarter, exceeding expectations, which reflects strong operational performance.
  • The company has a solid market capitalization of approximately $15.23 billion, indicating a stable position in the life sciences sector.
  • With a return on equity of nearly 29%, Illumina, Inc. demonstrates effective management and profitability, which can attract investors looking for strong returns.
  • Analysts have a consensus rating of "Hold" with an average target price of around $124.58, suggesting that there is room for price appreciation.

Illumina
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Illumina, Inc. for these reasons:

  • The company experienced a year-over-year revenue decline of 4.8%, which may raise concerns about its growth trajectory.
  • Illumina, Inc. has a price-to-earnings (P/E) ratio of 12.54, which, while not excessively high, may indicate that the stock is fairly valued given its recent performance.
  • With a beta of 1.37, the stock is more volatile than the market, which could pose risks for conservative investors.
  • Recent analyst ratings show a mix of "Hold" and "Sell" recommendations, indicating uncertainty about the stock's future performance.
  • The company has a debt-to-equity ratio of 0.66, which, while manageable, suggests that it is not entirely free from debt-related risks.

ILMN Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Illumina is $123.17, with a high forecast of $200.00 and a low forecast of $80.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last year. There are currently 2 sell ratings, 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ILMN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ILMN, but not buy additional shares or sell existing shares.

According to analysts, Illumina's stock has a predicted upside of 23.25% based on their 12-month stock forecasts.

Over the previous 90 days, Illumina's stock had 4 downgrades by analysts.

Analysts like Illumina less than other "medical" companies. The consensus rating for Illumina is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ILMN compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NASDAQ:ILMN) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel